Development and evaluation of glyburide fast dissolving tablets using solid dispersion techniqueVALLERI, M; MURA, P; MAESTRELLI, F et al.Drug development and industrial pharmacy. 2004, Vol 30, Num 5, pp 525-534, issn 0363-9045, 10 p.Article

Differential effects of glucose and glyburide on energetics and Na⁺ levels of βHC9 cells: Nuclear magnetic resonance spectroscopy and respirometry studiesDOLIBA, Nicolai M; VATAMANIUK, Marko Z; BUETTGER, Carol W et al.Diabetes (New York, NY). 2003, Vol 52, Num 2, pp 394-402, issn 0012-1797, 9 p.Article

Kir6.2-dependent high-affinity repaglinide binding to β-cell K_ATP channelsHANSEN, Ann Maria K; HANSEN, John Bondo; CARR, Richard D et al.British journal of pharmacology. 2005, Vol 144, Num 4, pp 551-557, issn 0007-1188, 7 p.Article

Glyburide Is Anti-inflammatory and Associated with Reduced Mortality in MelioidosisKOH, Gavin C. K. W; MAUDE, Rapeephan R; WHITE, Nicholas J et al.Clinical infectious diseases. 2011, Vol 52, Num 6, pp 717-725, issn 1058-4838, 9 p.Article

Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical PracticeHEBERT, M. F; MA, X; KELLY, E. J et al.Clinical pharmacology and therapeutics. 2009, Vol 85, Num 6, pp 607-614, issn 0009-9236, 8 p.Article

3 Sulfamides et cœur: Le point sur les données des principales études : Complications métaboliques induites par différents traitementsVERGES, Bruno.Diabète & obésité. 2014, Vol 9, Num 81, pp 203-205, issn 1957-5238, 3 p.Article

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapyKAHN, Steven E; HAFFNER, Steven M; VIBERTI, Giancarlo et al.The New England journal of medicine. 2006, Vol 355, Num 23, pp 2427-2443, issn 0028-4793, 17 p.Article

Sulfonylurées et effets cardiovasculaires : de l'expérimentation à la clinique. Données disponibles chez l'homme et implications cliniques = Sulfonylureas and cardiovascular effects : From the laboratory to the bedside, clinical data and implications in manRIVELINE, Jean-Pierre; VARROUD-VIAL, Michel; CHARPENTIER, Guillaume et al.STV. Sang thrombose vaisseaux. 2006, Vol 18, Num 7, pp 367-377, issn 0999-7385, 11 p.Article

Theoretical and experimental studies on the internal mobility of two sulfonylurea agents: glibenclamide and glimepirideWLODARCZYK, P; PALUCH, M; WOJNAROWSKA, Z et al.Journal of physics. Condensed matter (Print). 2011, Vol 23, Num 42, issn 0953-8984, 425901.1-425901.8Article

Transfer of glyburide and glipizide into breast milkFEIG, Denice S; BRIGGS, Gerald G; KOREN, Gideon et al.Diabetes care. 2005, Vol 28, Num 8, pp 1851-1855, issn 0149-5992, 5 p.Article

Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K⁺ channel activityKAWAKI, J; NAGASHIMA, K; SEINO, S et al.Diabetes (New York, NY). 1999, Vol 48, Num 10, pp 2001-2006, issn 0012-1797Article

Thermal degradation of amorphous glibenclamideREHDER, Sonke; SAKMANN, Albrecht; RADES, Thomas et al.European journal of pharmaceutics and biopharmaceutics. 2012, Vol 80, Num 1, pp 203-208, issn 0939-6411, 6 p.Article

Interaction of glibenclamide and metformin at the level of translation in pancreatic β cellsQIDI WANG; YING CAI; VAN DE CASTEELE, Mark et al.Journal of endocrinology. 2011, Vol 208, Num 2, pp 161-169, issn 0022-0795, 9 p.Article

Determination of Metformin Hydrochloride and Glyburide in an Antihyperglycemic Binary Mixture Using High-Performance Liquid Chromatographic-UV and Spectrometric MethodsSALEM, Hesham.Journal of AOAC International. 2010, Vol 93, Num 1, pp 133-140, issn 1060-3271, 8 p.Article

Glyburide for the treatment of gestational diabetesKREMER, Carrie J; DUFF, Patrick.American journal of obstetrics and gynecology. 2004, Vol 190, Num 5, pp 1438-1439, issn 0002-9378, 2 p.Article

Characterization of metabolites by ion-trap LC-MSⁿTILLER, P. R; LAND, A. P; JARDINE, I et al.American biotechnology laboratory. 2000, Vol 18, Num 3, pp 58-59, issn 0749-3223Article

Dissolution properties of glibenclamide in combinations with polyvinylpyrrolidoneIWATA, M; UEDA, H.Drug development and industrial pharmacy. 1996, Vol 22, Num 11, pp 1161-1165, issn 0363-9045Article

OATP1B3 Is Expressed in Pancreatic β-Islet Cells and Enhances the Insulinotropic Effect of the Sulfonylurea Derivative GlibenclamideMEYER ZU SCHWABEDISSEN, Henriette E; BOETTCHER, Kerstin; STEINER, Tobias et al.Diabetes (New York, NY). 2014, Vol 63, Num 2, pp 775-784, issn 0012-1797, 10 p.Article

Antidiabetic activity of aqueous bark extract of Cassia glauca in streptozotocin-induced diabetic ratsSALAHUDDIN, Md; JALALPURE, Sunil S; GADGE, Navneet B et al.Canadian journal of physiology and pharmacology. 2010, Vol 88, Num 2, pp 153-160, issn 0008-4212, 8 p.Article

Ultraviolet-Photodiode Array and High-Performance Liquid Chromatographic/Mass Spectrometric Studies on Forced Degradation Behavior of Glibenclamide and Development of a Validated Stability-Indicating MethodBANSAL, Gulshan; SINGH, Manjeet; KAUR CHAND JINDAL et al.Journal of AOAC International. 2008, Vol 91, Num 4, pp 709-719, issn 1060-3271, 11 p.Article

Optimization of glibenclamide tablet composition through the combined use of differential scanning calorimetry and D-optimal mixture experimental designMURA, P; FURLANETTO, S; CIRRI, M et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 1, pp 65-71, issn 0731-7085, 7 p.Article

The effect of gliclazide and glibenclamide on preconditioning of the human myocardiumLOUBANI, Mahmoud; FOWLER, Alan; STANDEN, Nicholas B et al.European journal of pharmacology. 2005, Vol 515, Num 1-3, pp 142-149, issn 0014-2999, 8 p.Article

In vitro and in vivo evaluation of glibenclamide in solid dispersion systemsTASHTOUSH, Bassam M; AL-QASHI, Zubaida S; NAJIB, Naji M et al.Drug development and industrial pharmacy. 2004, Vol 30, Num 6, pp 601-607, issn 0363-9045, 7 p.Article

Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2AMNON ZUNG; GLASER, Benjamin; NIMRI, Revital et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 11, pp 5504-5507, issn 0021-972X, 4 p.Article

GLIBENCLAMIDE REDUCES SECONDARY BRAIN DAMAGE AFTER EXPERIMENTAL TRAUMATIC BRAIN INJURYZWECKBERGER, K; HACKENBERG, K; JUNG, C. S et al.Neuroscience. 2014, Vol 272, pp 199-206, issn 0306-4522, 8 p.Article